Wyss Center for Bio and Neuroengineering
Swiss research institution founded by philanthropist Hansjorg Wyss, translating neuroscience discoveries into clinical applications including the ABILITY communication platform.
Overview
The Wyss Center is a Swiss research institution dedicated to translating basic neuroscience discoveries into clinical applications. Founded in 2014 by philanthropist Hansjorg Wyss, the center represents a model of philanthropic investment in applied neuroscience, operating independently from traditional academic and commercial pressures.
Mission and Focus
The Wyss Center emphasizes translational research, intentionally positioning itself between academic discovery and commercial deployment. The center works directly with patient populations to understand clinical needs and iteratively develop technologies that address real-world limitations of existing treatments and devices.
ABILITY Platform
The center is developing the ABILITY platform, a modular system for brain-computer communication designed specifically for paralyzed patients. The platform integrates neural recording, signal processing, and user interface design optimized for clinical usability and patient autonomy.
Global Partnerships
Wyss Center researchers collaborate internationally with leading BCI laboratories and commercial companies, contributing fundamental research while maintaining independence from market pressures. The center serves as a neutral space for methodological development and clinical validation.
Patient-Centered Research
Unlike many academic centers and commercial companies, Wyss Center explicitly prioritizes patient input and long-term outcome measurement. The center’s research philosophy emphasizes sustained engagement with paralyzed individuals rather than short-term proof-of-concept demonstrations.